PKM and experimental autoimmune encephalomyelitis: Similar to our current findings, Angiari et al. reported that TEPP-46, a small molecule inhibitor of PKM2 nuclear translocation, suppressed Th17 cell differentiation and ameliorated experimental autoimmune encephalomyelitis, although direct evidence of STAT3 suppression was not provided28.